Zobrazeno 1 - 10
of 577
pro vyhledávání: '"Junhu Zhou"'
Publikováno v:
npj Clean Water, Vol 7, Iss 1, Pp 1-11 (2024)
Abstract This study presents a dual-functional thin film, known as Ag nanoparticles decorated, ZnO nanorods coated silica nanofibers (AgNP-ZnONR-SNF), which demonstrates remarkable capabilities in both water purification and organic pollutants sensin
Externí odkaz:
https://doaj.org/article/c495bcf7625a4f2283563594b109c4da
Autor:
Xiaoteng Cui, Jixing Zhao, Guanzhang Li, Chao Yang, Shixue Yang, Qi Zhan, Junhu Zhou, Yunfei Wang, Menglin Xiao, Biao Hong, Kaikai Yi, Fei Tong, Yanli Tan, Hu Wang, Qixue Wang, Tao Jiang, Chuan Fang, Chunsheng Kang
Publikováno v:
Cancer Communications, Vol 43, Iss 12, Pp 1326-1353 (2023)
Abstract Background Metabolism reprogramming plays a vital role in glioblastoma (GBM) progression and recurrence by producing enough energy for highly proliferating tumor cells. In addition, metabolic reprogramming is crucial for tumor growth and imm
Externí odkaz:
https://doaj.org/article/00cb3e09a93e47169bf92b48fab6f99a
Autor:
Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu, Qixue Wang
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 5, Pp 385-400 (2023)
Objective: Epidermal growth factor receptor variant III (EGFRvIII) is a constitutively-activated mutation of EGFR that contributes to the malignant progression of glioblastoma multiforme (GBM). Temozolomide (TMZ) is a standard chemotherapeutic for GB
Externí odkaz:
https://doaj.org/article/8a1721fee85e4c6681a6b50fdfad6c5a
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 5, Pp 344-352 (2023)
Malignant gliomas are known to be one of the most difficult diseases to diagnose and treat because of the infiltrative growth pattern, rapid progression, and poor prognosis. Many antitumor drugs are not ideal for the treatment of gliomas due to the b
Externí odkaz:
https://doaj.org/article/a04f04e369ad47518ba0d9988f3f6328
Autor:
Tianhua Xue, Daolun Liang, Weiqiang Pang, Dekui Shen, Ammar Niamat, Jianzhong Liu, Junhu Zhou
Publikováno v:
FirePhysChem, Vol 2, Iss 4, Pp 340-356 (2022)
Metal fuels have a high potential for applications in space propulsion owing to their superior energy density and distinct combustion characteristics. Therefore, research into the combustion properties of metal fuels in microgravity has become necess
Externí odkaz:
https://doaj.org/article/14b2e9461aae481b9049f5ef5b3895d5
Autor:
Xiaoyang Zhang, Zesheng Li, Cheng Wei, Lin Luo, Shenghui Li, Junhu Zhou, Hao Liang, Ying Li, Lei Han
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor immune microenvironment plays an important role in tumorigenesis and metastasis. Polo-like kinases 4 (PLK4) is a crucial regulatory factor in the process of cell cycle, and its abnormal regulation often leads to a variety of diseases including
Externí odkaz:
https://doaj.org/article/0af885d540fd4b25b4301670df752a59
Publikováno v:
Materials Today Bio, Vol 14, Iss , Pp 100263- (2022)
Advancement of materials along with their fascinating properties play increasingly important role in facilitating the rapid progress in medicine. An excellent example is the recent development of biosensors based on nanomaterials that induce surface
Externí odkaz:
https://doaj.org/article/8574f7b501544bf5b4220d6546b26092
Autor:
Yingbin Xie, Luyue Chen, Junhu Zhou, Qixue Wang, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang, Chuan Fang
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 3, Pp 664-675 (2020)
Objective: Mesenchymal subtype of glioblastoma (mesGBM) is a refractory disease condition characterized by therapeutic failure and tumor recurrence. Hyperactive transforming growth factor-β (TGF-β) signaling could be a signature event in mesGBM, wh
Externí odkaz:
https://doaj.org/article/f42c911e965f41d899373e9e6e2f1929
Autor:
Chao Yang, Yanli Tan, Hongzhao Qi, Junhu Zhou, Lixia Long, Qi Zhan, Yunfei Wang, Xubo Yuan, Chunsheng Kang
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 2, Pp 433-443 (2020)
Objective: The introduction of therapeutic antibodies (tAbs) into clinical practice has revolutionized tumor treatment strategies, but their tumor therapy efficiency is still far below expectations because of the rapid degradation and limited tumor a
Externí odkaz:
https://doaj.org/article/ab95fdffcaef4d1883b65426042e766f
EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression
Autor:
Hongyu Zhao, Yunfei Wang, Chao Yang, Junhu Zhou, Lin Wang, Kaikai Yi, Yansheng Li, Qixue wang, Jin Shi, Chunsheng Kang, Liang Zeng
Publikováno v:
Clinical and Translational Medicine, Vol 9, Iss 1, Pp 1-15 (2020)
Abstract Background The EGFR-vIII mutation is the most common malignant event in GBM. Epigenetic reprogramming in EGFR-activated GBM has recently been suggested to downregulate the expression of tumour suppressor genes. Histone acetylation is importa
Externí odkaz:
https://doaj.org/article/6cc6edefc01140a9910ff5fb873dd0ea